Fusion from Carefx Goes Live at Cancer Therapy & Research Center, an NCI-designated Cancer Center in Texas

Tuesday, September 16, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SCOTTSDALE, Ariz., Sept. 15 Carefx Corporation todayannounced that the nationally recognized Cancer Therapy & Research Center(CTRC) at the University of Texas Health Science Center at San Antonio, Texas,has gone live after a 90-day implementation with Fusion from Carefx(R), aninteroperability platform that aligns patient data across multipleapplications to provide a complete view of patient health history.

One of only three National Cancer Institute-designated comprehensivecancer centers in Texas, CTRC, which was recently recognized as a Center ofExcellence by the Myelodysplastic Syndromes Foundation, selected Fusion fromCarefx for its ability to synchronize data from diverse systems including lab,pharmacy, medical records and PACs into a multidisciplinary view of patientrecords. As a result, CTRC clinicians can deliver care more efficiently.

Bogged down by multiple user IDs and passwords, redundant patient queriesand other struggles to access patient data more efficiently, CTRC staffembraced the opportunity to use Fusion. Where CTRC care providers had onceinvested excessive time accessing and retrieving information from disparatesystems, they began to save time with Fusion by navigating multiple, separatesystems using a single login and patient information search.

"Fusion allows our care providers to access comprehensive summaries ofpatient data that parallel cancer care processes in a fraction of the time ittook previously," said David Hotchkiss, CTRC's Director of InformationSystems. "With Fusion, our multidisciplinary clinical care team is able tosave precious time with the streamlined workflow and make more informedpatient care decisions."

In use at nearly 300 facilities nationwide, Fusion from Carefx seamlesslyintegrates patient information from diverse applications and databases at theuser-interface level. By implementing Fusion, CTRC has saved on expensesassociated with deploying multiple interfaces for database integration and haskept its overall cost of ownership down. Fusion presents the user with astreamlined look at relevant clinical data, where and when the user needs it.Fusion reduces the time CTRC clinicians must invest in searching for andaccessing information needed to diagnose and treat patients.

"Carefx worked closely with our team to understand the unique needs ofCTRC and the approach we use in delivering care to cancer patients," Hotchkisssaid. "Carefx took the time to clearly comprehend our requirements byanalyzing workflows and understanding the optimal user experience. Theydelivered a solution that not only met our requirements but also beat anon-budget and aggressive 90-day implementation schedule."

"Carefx understands that CTRC, and every other healthcare organization,needs to leverage their existing technology investments," said Andrew Hurd,Chairman and CEO of Carefx. "We take great pride in solving the challenge ofaccessing patient data from multiple systems and removing time-wastingworkflow obstacles, rapidly and cost effectively. As a company, we are drivenby the desire to play our part in helping our customers improve clinicalefficacy and quality care."

About Carefx Corporation

Scottsdale, Ariz.-based Carefx is the only provider of an open, scalablepatient data aggregation platform that provides clinicians with real-timeaccess to information residing in disparate clinical applications. Fusionfrom Carefx(R) can be operated either in a desktop or a web-based environmentand is customizable to each user's workflow. For more information, visitwww.carefx.com .

About CTRC

The Cancer Therapy & Research Center (CTRC) at The University of TexasHealth Science Center at San Antonio is one of the nation's leading academicresearch and treatment centers, serving more than 4.4 million people in thehigh-growth corridor of Central and South Texas including Au

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store